Overview
Pancytopenia with developmental delay syndrome encompasses several rare genetic syndromes characterized by hematological abnormalities (such as pancytopenia) alongside developmental delays and multisystemic involvement including skeletal, cardiac, gastrointestinal, and ocular anomalies. 1Diagnosis
Genetic Testing: Identification of specific pathogenic variants (e.g., ZNF699, TBL1XR1, chromosome deletions) is crucial 1234.
Clinical Features: Look for developmental delay, characteristic facial dysmorphism, skeletal malformations, gastrointestinal issues, cardiac abnormalities, and ocular abnormalities 1.
Ocular Examination: Detailed assessment for abnormalities such as microphthalmia, nystagmus, and other visual system defects 12.
Hematological Evaluation: Complete blood count (CBC) to identify pancytopenia or other hematological abnormalities 1.
Imaging and Specialized Tests: Utilize imaging studies (e.g., skeletal surveys, echocardiography) and audiometry for hearing loss 123.Management
Supportive Care: Address specific organ system dysfunctions (e.g., cardiac support, nutritional management for growth failure) 14.
Developmental Interventions: Early intervention programs focusing on physical, occupational, and speech therapy 1.
Genetic Counseling: Essential for families to understand recurrence risks and implications 13.
Hematopoietic Support: Consider blood transfusions or other supportive measures for severe pancytopenia 1.Special Populations
Pediatrics: Early identification and multidisciplinary management are critical for improving developmental outcomes 1.
Comorbidities: Monitor and manage associated conditions like gastrointestinal issues, cardiac defects, and hearing loss 123.Key Recommendations
Perform comprehensive genetic testing including whole exome sequencing to identify specific pathogenic variants associated with the syndrome (Evidence: Moderate 1234).
Implement multidisciplinary care teams including geneticists, pediatricians, hematologists, and developmental specialists to address multisystem involvement (Evidence: Expert opinion).
Initiate early intervention programs tailored to developmental delays and physical impairments (Evidence: Moderate 1).
Regularly assess and manage hematological abnormalities with appropriate supportive therapies (Evidence: Weak 1).
Offer genetic counseling to families to discuss inheritance patterns and recurrence risks (Evidence: Expert opinion).References
1 Ali SM, AlMasri DA, Prada CE, Lin D, Bosley TM, Kozak I. Clinical and ocular abnormalities in DEGCAGS syndrome-Developmental delay with gastrointestinal, cardiovascular, genitourinary, and skeletal abnormalities. Molecular genetics & genomic medicine 2024. link
2 Kahlert AK, Weidensee S, Mackenroth L, Porrmann J, Rump A, Di Donato N et al.. Pierpont syndrome: report of a new patient. Clinical dysmorphology 2017. link
3 Keppler-Noreuil K, Welch J, Baker-Lange K. Syndrome of congenital cataracts, sensorineural deafness, Down syndrome-like facial appearance, short stature, and mental retardation: two additional cases. American journal of medical genetics. Part A 2007. link
4 Menten B, Buysse K, Zahir F, Hellemans J, Hamilton SJ, Costa T et al.. Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14. Journal of medical genetics 2007. link
5 Stewart H, Kerr B, Tomlin P, Stacey D, Super M. Sibs with developmental delay, hirsutism and nail hypoplasia: a new syndrome. Clinical dysmorphology 2000. link
6 Partington M, Anderson D. Mild growth retardation and developmental delay, microcephaly, and a distinctive facial appearance. American journal of medical genetics 1994. link
7 Lin HJ, Kakkis ED, Eteson DJ, Lachman RS. DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive cases. American journal of medical genetics 1993. link